Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

 

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium
G

Impact of COVID-19 on Recipients of HCT and CAR T-Cells

By Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium FEATURING Gunjan Shah
By Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium FEATURING Gunjan Shah
4 views
September 9, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Keynote and Plenary Sessions
13:06

Penn Medicine Q&A Panel on Cell Therapy During the COVID-19 Pandemic

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. Porter, C. Bollard, G. Shah, S. Maude, S. Devine

11 views
29:34

Penn Medicine Highlights on the Future of Cell and Gene Therapies fo…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

C. June

123 views
09:10

Penn Medicine Panel Discussion on Overcoming Resistance to Monothera…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

S. Maude, N. Frey, M. Pule, D. Miklos

15 views
17:06

Pediatric CAR T-Cell Therapy During COVID-19: CHOP Experience

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

S. Maude

18 views
50:17

Penn Medicine Updates on Creating Smarter T Cells for Immunotherapy

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

S. Riddell

88 views
17:25

AUTO3 and Beyond: Experience With Co-targeting of CD19 and CD22 in D…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

M. Pule

22 views
22:42

Bispecific CAR19-22 and Sequential CAR22 Rescue: The Experience of a…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. Miklos

11 views
08:58

Developing CAR T-Cell Therapies in Brazil

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

R. Cunha

25:36

Impact of COVID-19 on Recipients of HCT and CAR T-Cells

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

G. Shah

08:57

Decade-Long Remissions of Leukemia Sustained by the Persistence of A…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

J. Joseph Melenhorst

14:21

Penn Medicine Q&A Discussion on CAR T-Cell Therapy in Hematologic Ma…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

R. Maziarz, T. Fry, A. Garfall, D. Maloney

19 views
14:40

Penn Medicine Updates on CAR T-Cell Therapy for Lymphoma

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. Maloney

30 views
18:36

Penn Medicine Updates on CAR T-Cell Therapy for Multiple Myeloma

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

A. Garfall

55 views
16:48

The Future of CAR T-Cell Therapy for ALL

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

T. Fry

16 views
14:38

CART22-65s Co-administered With huCART19 in Adult Patients With R/R …

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

N. Frey

14 views